Viking Therapeutics, Inc. (VKTX) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Find Viking Therapeutics, Inc. (VKTX) short-term stock forecasts for 2025 by month and long-term price predictions for 2025 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest VKTX stock news and headlines.
1 Month Prediction
$157.42 [416.47%]
3 Month Prediction
$123.81 [306.20%]
6 Month Prediction
$114.65 [276.16%]
1 Year Prediction
$150.27 [393.02%]
3 Year Prediction
$245.13 [704.24%]
5 Year Prediction
$330.44 [984.13%]
About Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California. The company develops new therapies for metabolic and endocrine disorders.
Viking has several compounds in clinical trials:
- VK2809: This is a selective thyroid hormone receptor beta agonist. It is being tested for non-alcoholic steatohepatitis (NASH) and fibrosis.
- VK2735: This dual agonist targets GLP-1 and GIP receptors. It is under evaluation for obesity treatment.
- VK0214: This compound treats X-linked adrenoleukodystrophy (X-ALD). It is currently in a Phase 1b trial and has shown reduction in harmful fatty acids.
Viking Therapeutics, Inc. (VKTX) Historical Performance
IPO Date
Viking Therapeutics, Inc. (NASDAQ:VKTX) went public on 29 April, 2015.
Change
Since inception, VKTX has increased by 246.36%. In the last 5 years, VKTX has risen from $4.68 to $30.48, a massive 551.28% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $82.00 and a low of $2.22.
52 Week Range
$28.64
$99.41
The current price $30.48 is near the 52-week low, which means that the stock is underbought.
VKTX Stock Price History
Based on VKTX stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the VKTX stock has risen from $4.68 - $7.21 to $30.48 - $32.75, which is up 310.04%. Currently, the stock follows upward trend.
Here, we have calculated stock range of VKTX, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $4.68 - $7.21 | $6.19 | -19.7 | 1 Year Change |
| 2021 | $4.6 - $7.31 | $6.06 | -21.39 | 2 Year Change |
| 2022 | $2.22 - $9.4 | $3.67 | -52.39 | 3 Year Change |
| 2023 | $8.76 - $21.96 | $14.66 | 90.17 | 4 Year Change |
| 2024 | $24.14 - $82.0 | $60.68 | 687.13 | 5 Year Change |
| 2025 | $30.48 - $32.75 | $31.61 | 310.04 | 6 Year Change |
VKTX Price Performance
6-Month Performance
VKTX stock dropped by 51.86% in the last six months.
1-Year Performance
The stock has trended downwards by 62.83% in the past year.
3-Year Performance
In the last 3 years, the stock has soared by 916.00%.
5-Year Performance
In the last 5 years, the stock has gone up by 551.28%.
According to Viking Therapeutics, Inc.'s historical data, below graph gives us the exact picture of how the VKTX stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2020
29.80% ↓
2021
18.29% ↓
2022
104.35% ↑
2023
97.98% ↑
2024
116.23% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Viking Therapeutics, Inc. (VKTX) Financials & Stock Analysis
Market Capitalization
Viking Therapeutics, Inc. has a market capitalization of $3.40B, which places VKTX in the mid-cap category.
Fundamental Analysis
EPS: $-0.22 (Q3), $-0.91 (1Y)
EPS increased 10.00% since last quarter, and increased 1.11% since last year.
Net Income: $-24.94 M (Q3), $-85.89 M (1Y)
Net Income increased 12.09% since last quarter, and increased 24.73% since last year.
Free Cash Flow: $-21.96 M (Q3), $-73.38 M (1Y)
Free Cash Flow decreased N/A since last quarter, and increased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for VKTX stock. These indicators help you understand Viking Therapeutics, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for VKTX stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $32.37 |
| SMA50 | $38.90 |
| SMA200 | $55.41 |
| RSI | 39.12 |
| Beta | 0.89 |
SMA20 > Current Price
This signals VKTX stock is in short-term bearish momentum.
SMA50 > Current Price
This signals VKTX stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals VKTX stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for VKTX stock is Bearish. Out of all indicators, 2 indicates bullish signals, 4 signals bearish trends and 3 gives neutral trends. The VKTX stock forecast was last updated on 18 February, 2025.
Viking Therapeutics, Inc. (VKTX) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $92.32 by the end of 2025, and can reach around $135.26 to $174.60 in 2026. And, the long-term forecast suggests that the stock may further jump to $234.46 - $142.66 in 2028, and $446.20 - $26.63 by 2031. So, the VKTX stock shows a strong upward trend in the next several years.
Short-term VKTX Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $157.42 | 416.47% |
| 2025-04 | $148.30 | 386.55% |
| 2025-05 | $123.81 | 306.2% |
| 2025-06 | $108.75 | 256.79% |
| 2025-07 | $108.42 | 255.71% |
| 2025-08 | $114.65 | 276.15% |
| 2025-09 | $95.31 | 212.7% |
| 2025-10 | $88.38 | 189.96% |
| 2025-11 | $87.34 | 186.55% |
| 2025-12 | $92.32 | 202.89% |
In 2025, the VKTX stock price is expected to fluctuate between $87.34 and $157.42. According to the monthly forecast, the stock could rise to $92.32 by December 2024. If compared to the VKTX's current price, the stock could gain 202.89% by the end of this year.
Long-term VKTX Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $135.26 | $85.84 | $174.60 | 472.83% |
| 2027 | $120.85 | $136.71 | $293.04 | 861.42% |
| 2028 | $234.46 | $131.41 | $142.66 | 368.04% |
| 2029 | $106.83 | $313.16 | $468.99 | 1438.68% |
| 2030 | $531.94 | $177.13 | $533.02 | 1648.75% |
| 2031 | $446.20 | $-52.27 | $26.63 | -12.63% |
| 2032 | $575.77 | $460.08 | $182.51 | 498.79% |
| 2033 | $653.01 | $530.75 | $139.06 | 356.23% |
| 2034 | $648.43 | $374.09 | $319.18 | 947.18% |
| 2035 | $869.76 | $182.77 | $239.47 | 685.66% |
| 2036 | $822.14 | $564.24 | $843.95 | 2668.86% |
| 2037 | $771.13 | $316.12 | $511.17 | 1577.07% |
| 2038 | $225.76 | $828.04 | $850.53 | 2690.45% |
| 2039 | $840.50 | $423.25 | $730.94 | 2298.1% |
| 2040 | $1315.47 | $1047.77 | $895.33 | 2837.43% |
| 2041 | $242.05 | $974.11 | $949.65 | 3015.65% |
| 2042 | $624.08 | $668.62 | $1006.31 | 3201.54% |
| 2043 | $607.72 | $317.02 | $1071.55 | 3415.58% |
| 2044 | $1333.59 | $945.54 | $1350.40 | 4330.45% |
| 2045 | $1876.77 | $1769.62 | $927.28 | 2942.26% |
| 2046 | $1145.34 | $72.00 | $752.54 | 2368.96% |
| 2047 | $1186.76 | $741.04 | $580.14 | 1803.35% |
| 2048 | $215.67 | $1126.46 | $2059.56 | 6657.09% |
| 2049 | $1339.08 | $1923.40 | $1298.54 | 4160.3% |
| 2050 | $1359.63 | $1128.36 | $1014.67 | 3228.97% |
| 2051 | $2690.05 | $284.56 | $1208.80 | 3865.88% |
Viking Therapeutics, Inc. (VKTX) Stock Price Prediction & Forecast 2025
At the start of 2025, the VKTX stock was at $32.75. Today, it is trading at $30.48, which is -6.93% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $92.32 by December 2025 with a 202.89% change.
Viking Therapeutics, Inc. (VKTX) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the VKTX stock. During this period, the VKTX's price is forecasted to shift from $135.26 to $533.02, which is 294.07% gain.
In 2026, the stock would possibly open at $135.26, descends to $85.84 by mid-year, and wraps up at $174.60, reflecting a 472.83% increase from today's price. Further moving to 2030, the stock can kick off the year at $531.94, drop to $177.13 by mid-year, and finish at $533.02, which is 1648.74% change from current price.
Viking Therapeutics, Inc. (VKTX) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $446.20 to $895.33, which is up -12.63%
In 2031, we can expect VKTX to fluctuate between $26.63 and $446.20, a shift indicating a -12.63% loss by year-end compared to current price. And Until 2040, VKTX can likely vary from $895.33 to $1315.47. By the end of 2040, the stock could record a 2837.43% rise from today's stock price.
Viking Therapeutics, Inc. (VKTX) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the VKTX stock can see an an upturn from $242.05 to $1014.67 in this period. In 2041, the stock can experience a high of $974.11 by mid-year, closing the year at $949.65. This results in a 3095.90% increase from today.
Moving towards the end of 2050, VKTX is projected to open the year at $1359.63. The stock may dip to $1128.36 during mid-year and finish the year at $1014.67. Compared to the stock's current price, this translates to an overall gain of 3228.96% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
VKTX Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| ADTX | Aditxt, Inc. | - | $0.07 | -34.58% ▼ | $1328.57 ▲ |
| CRSP | CRISPR Therapeutics AG | - | $49.72 | 19.55% ▲ | $90.65 ▲ |
| GALT | Galectin Therapeutics Inc. | - | $1.41 | 12.80% ▲ | $268.23 ▲ |
| MBRX | Moleculin Biotech, Inc. | - | $2.18 | 44.37% ▲ | $336.52 ▲ |
| MNMD | Mind Medicine (MindMed) Inc. | - | $9.89 | 45.66% ▲ | $96.36 ▲ |
Last updated Feb 18 at 2:41 AM
VKTX : Buy, Sell Or Hold?
Analyst Ratings
Based on 15 analysts, 6 rated as a strong buy, 8 recommended a buy, 1 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 14 analysts, 5 analysts gave a strong buy rating, 9 a buy rating, 0 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for VKTX stock is Buy.
Expert Analysis
According to VKTX short-term and long-term forecast, Viking Therapeutics, Inc. shares are projected to go up by 3228.97%, and reach a value of $1014.67 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, VKTX has recorded 11/30 green days, which reflects a 50.0% positivity rate with a price volatility of 0.04%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that VKTX stock is undervalued. So, Based on VKTX prediction and analysis, it may be the best time to hold VKTX stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "VKTX” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.